Atlas FDA

Sodium Hyaluronate Ophthalmic Viscoelastic Device (OVD), Healon GV PRO

FDA premarket approval P810031/S066 · decided 2020-11-25

Approval details

PMA number
P810031
Supplement
S066
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Sodium Hyaluronate Ophthalmic Viscoelastic Device (OVD), Healon GV PRO
Generic name
AID, SURGICAL, VISCOELASTIC
Applicant
Johnson & Johnson Surgical Vision, Inc.
Date received
2020-03-09
Decision date
2020-11-25
Days to decision
261 days
Decision code
APPR
Product code
LZP
Advisory committee
Ophthalmic
Expedited review
No
Location
Irvine, CA
Statement
Approval for changes in labeling to include a new Warning, modifications to the Device Description and Precautions, and the addition of two surgical techniques for removal of the Healon GV® PRO OVD from the eye.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ELITA™ Femtosecond Laser System, ELITA™ Patient Interface (K223566)Johnson & Johnson Surgical Vision, Inc.2023-04-14
VERITAS Phacoemulsification Console, VERITAS Advanced Fluidics Pack and Advanced Infusion Pack, VERITAS Swivel Handpiece, VERITAS Advanced Foot Pedal, VERITAS Remote Control (K203060)Johnson & Johnson Surgical Vision, Inc.2021-03-12
UNFOLDER Vitan Inserter (K191949)Johnson & Johnson Surgical Vision, Inc.2019-09-13
COMPACT INTUITIV System, COMPACT INTUITIV Wireless Remote Control, COMPACT INTUITIV Four-Button Foot Pedal, COMPACT INTUITIV Closed-Toe Foot Pedal (K191933)Johnson & Johnson Surgical Vision, Inc.2019-08-16